Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent End-Stage Renal Disease (ESRD) (SPin-D) Trial

NCT02285920 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02285920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02285920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent End-Stage Renal Disease (ESRD) (SPin-D) Trial
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2014
Completion date
July 30, 2017
Enrollment
129 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease